Etiket: Clinical Research

Clinical laboratories are of critical importance in the medical field for accurate diagnosis and treatment. Today, the increasing number of patients and complex test demands have highlighted the need for speed, precision, and efficiency in laboratories. At this point, CLIA (Chemiluminescent Immunoassay) technology offers solutions that elevate laboratory performance to the next level. Innovative devices like INNOVIQURE NEXUS maximize the potential of this technology, making a significant impact in the industry.

What is CLIA Technology and Why is It Important?

CLIA technology is used in medical diagnostic tests, particularly for detecting biomarkers at low levels. This technology is based on measuring the light emitted as a result of a chemical reaction and stands out with the following advantages:

• Sensitivity: The ability to detect even low concentrations of biomarkers.
• Fast Results: Reliable test outcomes in a short period of time.
• Versatility: The capacity to analyze various types of biomarkers.

These features enable laboratories to work more effectively and make quicker decisions in patient care.

INNOVIQURE NEXUS: Integration of CLIA Technology

INNOVIQURE NEXUS is one of the most efficient solutions utilizing CLIA technology. This innovative device has numerous features that facilitate laboratory workflows:

• Compact Design: Weighing less than 38 kg, it is ideal for use in various settings.
• User-Friendly Interface: Its touchscreen and simple control panel make it easy to operate.
• High Capacity: Offers 30 sample and 10 reagent positions with 24-hour uninterrupted cooling and storage.
• Smart Functions: Optimized alarm classification and compatibility with all Shine series analyzers’ reagents and consumables.

Accelerating Transformation in Laboratories

The fast, precise, and efficient performance offered by INNOVIQURE NEXUS redefines workflows in clinical laboratories. Its user-friendly interface allows laboratory staff to operate the device with ease and conduct tests with fewer errors. Additionally, the STAT channel enables much faster analysis of urgent samples.

A Step Towards the Future

The rapid advancement in medical technologies is making laboratory processes more efficient, and innovative devices like INNOVIQURE NEXUS are leading this transformation. Supported by the features of CLIA technology, this device provides a versatile solution for the present and future of laboratories.

Contact us to bring the INNOVIQURE NEXUS advantage to your laboratory: [email protected]

A major step forward in the early diagnosis of cardiovascular diseases: The high-sensitivity cardiac troponin I (hs-cTnI) test is revolutionising this field. SHD Test is pioneering this innovation by contributing not only to clinical results but also to academic research.

Clinical Accuracy and Reliability
Troponin I protein is one of the most reliable biomarkers for detecting cardiac muscle damage. SHD Test’s hs-cTnI solution is accurate even at very low levels of 5 pg/ml. This enables early diagnosis as well as rapid detection of even less obvious cases. This high accuracy reduces false negative rates, especially in low-risk patients.

New Approaches in Diagnostic Technology
The devices offered by SHD Test stand out with their high sensitivity as well as their portability and fast result capability. These features are particularly suitable for use in intensive care units, emergency services and mobile health platforms. The widespread use of high-sensitivity testing ensures more consistent clinical results and helps to make faster and more informed decisions in patient management.

Scientific Collaborations and Expanding Opportunities
SHD Test aims to support innovative projects in the academic world. To this end, it offers hs-cTnI tests free of charge for use in research projects. This enables the development of new diagnostic protocols and independent validation of existing approaches. Thus, while contributing to the academic literature, gaps in clinical practice are also filled.

Personalised Medicine and POCT Trends
In the healthcare sector, personalised medicine and portable diagnostic devices (POCT) are becoming increasingly important. hs-cTnI tests epitomise this trend, increasing patient satisfaction and improving the efficiency of healthcare systems. SHD Test’s technology not only meets these demands, but also contributes to the establishment of new diagnostic standards.

Steps for the Future
The hs-cTnI test not only improves current diagnostic methods, but also lays the foundation for future healthcare innovations. We invite the academic and clinical communities to explore and develop these innovations. Please contact us for further information and collaboration opportunities.

In the rapidly evolving world of healthcare, timely and accurate diagnostics have always been at the forefront of better patient outcomes. One of the latest breakthroughs in this field comes from implementing high-sensitivity cardiac troponin I (hs-cTnI) tests on point-of-care testing (POCT) devices. This innovation promises to revolutionize emergency diagnostics and mobile healthcare, setting a new standard for rapid and reliable patient care.

High-Sensitivity, Rapid Diagnostics: A Game-Changer
The hs-cTnI test is a cornerstone for diagnosing cardiac events, such as myocardial infarctions, and its integration into POCT devices is nothing short of revolutionary. Traditionally, such tests required centralized labs, delaying crucial decisions in emergency departments and mobile units. With our implementation, these barriers are eliminated:

Exceptional Sensitivity: Ensures reliable detection of cardiac biomarkers.
Rapid Turnaround Times: Facilitates faster clinical decisions during critical moments.
These improvements enable healthcare professionals to act swiftly and confidently, saving lives and enhancing the overall patient experience.

An Open Invitation to the Academic Community
To further validate and expand the potential of this innovation, we’re inviting researchers and academics to join hands with us. Whether your expertise lies in comparative studies, independent evaluations, or clinical publications, we offer an unparalleled opportunity:

Free Access to Our Systems and Tests: Our POCT devices and hs-cTnI tests are available at no cost for qualified academic and clinical research.
Support for High-Impact Research: Collaborate with us to generate groundbreaking findings for publication in leading journals.
This partnership aims to create a robust body of evidence, setting new benchmarks in diagnostics and paving the way for widespread adoption of this life-saving technology.

The Impact of Collaboration
By working together, we can redefine what’s possible in patient care. Academic contributions are crucial to ensuring the credibility and utility of this technology across diverse settings. From urban emergency rooms to remote mobile units, the potential applications are vast.

Through these collaborations, we aim to:

Validate the effectiveness of hs-cTnI in real-world scenarios.
Encourage global standardization of POCT diagnostics.
Inspire innovative approaches to healthcare challenges.
Join Us in Shaping the Future of Healthcare
This is more than a call for collaboration—it’s an opportunity to be part of a transformative journey. If you are passionate about advancing medical science and making a tangible impact on patient care, we want to hear from you. Let’s combine our expertise to create a future where diagnostics are faster, smarter, and more accessible to everyone.

Reach out to us today for more information about this initiative. Together, we can drive innovation and make a lasting difference in healthcare worldwide.

To contact us